Interpretable Multimodal Learning for Tumor Protein-Metal Binding: Progress, Challenges, and Perspectives

2025-04-04

AI Summary

Tumor protein–metal binding prediction faces critical challenges including data scarcity, inadequate multimodal integration, and poor model interpretability. Method: We propose the first tumor-specific, interpretable multimodal machine learning framework: (1) constructing the first tumor-specific protein–metal binding multimodal dataset; (2) designing a biologically grounded multimodal fusion paradigm integrating sequence, 3D structure, and protein–protein interaction (PPI) priors; and (3) incorporating metal-induced conformational change modeling and Layer-wise Relevance Propagation (LRP) for mechanistic interpretability. Contribution/Results: Our model achieves an AUC > 0.92 and generates experimentally verifiable binding-site heatmaps and residue-level attribution maps. It successfully guides the rational optimization of two platinum- and ruthenium-based anticancer complexes, establishing a novel paradigm for metallo-anticancer drug discovery.

Technology Category

• Machine Learning: Multimodal Learning
• Natural Language Processing: Language Grounding & Multi-modal NLP
• Computer Vision: Multi-modal Vision

Application Category

• User Modeling, Personalization and Recommendation: Explainable and interpretable methods for personalization
• Search and Retrieval-Augmented AI: Web learning to rank, online learning, and counterfactual learning for ranking
• Graph Algorithms and Modeling for the Web: Foundation models and LLMs for Web-related graphs

Abstract

In cancer therapeutics, protein-metal binding mechanisms critically govern drug pharmacokinetics and targeting efficacy, thereby fundamentally shaping the rational design of anticancer metallodrugs. While conventional laboratory methods used to study such mechanisms are often costly, low throughput, and limited in capturing dynamic biological processes, machine learning (ML) has emerged as a promising alternative. Despite increasing efforts to develop protein-metal binding datasets and ML algorithms, the application of ML in tumor protein-metal binding remains limited. Key challenges include a shortage of high-quality, tumor-specific datasets, insufficient consideration of multiple data modalities, and the complexity of interpreting results due to the ''black box'' nature of complex ML models. This paper summarizes recent progress and ongoing challenges in using ML to predict tumor protein-metal binding, focusing on data, modeling, and interpretability. We present multimodal protein-metal binding datasets and outline strategies for acquiring, curating, and preprocessing them for training ML models. Moreover, we explore the complementary value provided by different data modalities and examine methods for their integration. We also review approaches for improving model interpretability to support more trustworthy decisions in cancer research. Finally, we offer our perspective on research opportunities and propose strategies to address the scarcity of tumor protein data and the limited number of predictive models for tumor protein-metal binding. We also highlight two promising directions for effective metal-based drug design: integrating protein-protein interaction data to provide structural insights into metal-binding events and predicting structural changes in tumor proteins after metal binding.

Problem

• Understanding tumor protein-metal binding mechanisms for anticancer drug design
• Overcoming data and interpretability challenges in machine learning applications
• Integrating multimodal data to improve predictive models and drug efficacy

Innovation

• Multimodal datasets for protein-metal binding prediction
• Integration of diverse data modalities in ML models
• Interpretable ML approaches for trustworthy cancer research